Literature DB >> 32179919

Hospital Readmissions After Laboratory-Confirmed Influenza Hospitalization.

David M Dobrzynski1, Danielle N Ndi2, Yuwei Zhu3, Tiffanie Markus2, William Schaffner2,4, H Keipp Talbot2,4.   

Abstract

BACKGROUND: Influenza infection causes substantial morbidity and mortality. However, little is known about hospital readmissions after an influenza hospitalization. The aim of our study was to characterize frequency of hospital readmissions among patients hospitalized with laboratory-confirmed influenza.
METHODS: We conducted a retrospective study using Tennessee Emerging Infections Program Influenza Surveillance data from 2006 to 2016 and the concurrent Tennessee Hospital Discharge Data System. We analyzed demographic characteristics and outcomes to better understand frequency and factors associated with hospital readmissions.
RESULTS: Of the 2897 patients with a laboratory-confirmed influenza hospitalization, 409 (14%) and 1364 (47%) had at least 1 hospital readmission within 30 days and 1 year of the influenza hospitalization, respectively. Multiple readmissions occurred in 739 patients (54%). The readmission group was older, female predominant, and had more comorbidities than patients not hospitalized. Pneumonia, acute chronic obstructive pulmonary disease/asthma exacerbation, septicemia, acute respiratory failure, and acute renal failure were the most common causes for readmission at 30 days. Underlying cardiovascular disease, lung disease, kidney disease, diabetes, immunosuppression, and liver disease were associated with increased risk of readmission during the subsequent year.
CONCLUSIONS: After an admission with laboratory-confirmed influenza, there is a high likelihood of readmission within 30 days and 1 year adding to the morbidity of influenza.
© The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  comorbidities; emerging infections network; hospital readmissions; influenza

Mesh:

Year:  2020        PMID: 32179919     DOI: 10.1093/infdis/jiaa117

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  5 in total

1.  Poor prognosis indicators of type-2 diabetic COVID-19 patients.

Authors:  R Gorjão; S M Hirabara; L N Masi; T D A Serdan; R B Gritte; E Hatanaka; T Souza-Siqueira; A C Pithon-Curi; T M de Lima; T C Pithon-Curi; J F M Marchini; M C C Machado; H P Souza; R Curi
Journal:  Braz J Med Biol Res       Date:  2022-06-22       Impact factor: 2.904

2.  Identification of Barriers Limiting the Use of Preventive Vaccinations against Influenza among the Elderly Population: A Cross-Sectional Analysis.

Authors:  Alicja Pietraszek; Małgorzata Sobieszczańska; Sebastian Makuch; Mateusz Dróżdż; Grzegorz Mazur; Siddarth Agrawal
Journal:  Vaccines (Basel)       Date:  2022-04-20

3.  Assessment of thirty-day readmission rate, timing, causes and predictors after hospitalization with COVID-19.

Authors:  I Yeo; S Baek; J Kim; H Elshakh; A Voronina; M S Lou; J Vapnik; R Kaler; X Dai; S Goldbarg
Journal:  J Intern Med       Date:  2021-02-05       Impact factor: 13.068

4.  Evaluation of step-down oral antibiotic therapy for uncomplicated streptococcal bloodstream infections on clinical outcomes.

Authors:  Amy Kang; Richard Beuttler; Emi Minejima
Journal:  Ther Adv Infect Dis       Date:  2022-01-30

Review 5.  Hospital readmissions and emergency department re-presentation of COVID-19 patients: a systematic review.

Authors:  Sasha Peiris; Joseph L Nates; Joao Toledo; Yeh-Li Ho; Ojino Sosa; Victoria Stanford; Sylvain Aldighieri; Ludovic Reveiz
Journal:  Rev Panam Salud Publica       Date:  2022-10-10
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.